bis(4-piperidinophenol)diimidonaphthalene-1,4,5,8-tetracarboxylic acid dibenzosulfoethylate has been researched along with nafoxidine in 1 studies
| Studies (bis(4-piperidinophenol)diimidonaphthalene-1,4,5,8-tetracarboxylic acid dibenzosulfoethylate) | Trials (bis(4-piperidinophenol)diimidonaphthalene-1,4,5,8-tetracarboxylic acid dibenzosulfoethylate) | Recent Studies (post-2010) (bis(4-piperidinophenol)diimidonaphthalene-1,4,5,8-tetracarboxylic acid dibenzosulfoethylate) | Studies (nafoxidine) | Trials (nafoxidine) | Recent Studies (post-2010) (nafoxidine) |
|---|---|---|---|---|---|
| 40 | 1 | 2 | 243 | 7 | 3 |
| Protein | Taxonomy | bis(4-piperidinophenol)diimidonaphthalene-1,4,5,8-tetracarboxylic acid dibenzosulfoethylate (IC50) | nafoxidine (IC50) |
|---|---|---|---|
| Estrogen receptor | Rattus norvegicus (Norway rat) | 0.0409 | |
| Estrogen receptor beta | Rattus norvegicus (Norway rat) | 0.0409 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jeannin, E; Liu, JW; Picard, D | 1 |
1 other study(ies) available for bis(4-piperidinophenol)diimidonaphthalene-1,4,5,8-tetracarboxylic acid dibenzosulfoethylate and nafoxidine
| Article | Year |
|---|---|
The anti-estrogen hydroxytamoxifen is a potent antagonist in a novel yeast system.
Topics: Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Humans; Indoles; Nafoxidine; Piperidines; Polyunsaturated Alkamides; Receptors, Estrogen; Saccharomyces cerevisiae; Sulfones; Tamoxifen; Two-Hybrid System Techniques | 1999 |